| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00377143 Details | 2012-02-16 Interventional | 4 | 0 | Warfarin Blood Coagulati… Hemostatic Diso… | similar large study planned by NHLBI - | |||
| NCT00040014 Details | 2012-02-16 Interventional | 2 | - | Exemestane Breast Neoplasm… | - - | |||
| NCT00936195 Details | 2012-02-15 Interventional | 3 | 0 | Efavirenz Emtricitabine Lamivudine Lamivudine, zid… Lopinavir Ritonavir Tenofovir Zidovudine Acquired Immuno… Communicable Di… HIV Infections Infections Breastfeeding HIV Infection Pregnancy | faillure to obtain insurance because of refusal from insurance companies - | |||
| NCT00368381 Details | 2012-02-13 Interventional | 4 | [15 Refs] | 0 | Hydrocortisone Adrenal Insuffi… Sepsis Toxemia | Study closed for PI failure to submit renewal paperwork - | ||
| NCT01452009 Details | 2012-02-10 Interventional | 3 | 0 | Ophthalmic Solu… Travoprost Glaucoma Glaucoma, Open-… Hypertension Ocular Hyperten… Open Angle Glau… | Management Decision - | |||
| NCT00389090 Details | 2012-02-09 Interventional | 2 | 32 | O(6)-benzylguan… Temozolomide Astrocytoma Glioma Oligodendroglio… Oligoastrocytom… | AOI Pharma terminated the license agreement. IND Transferred to NCI - | |||
| NCT01273779 Details | 2012-02-03 Interventional | 2/3 | - | Talactoferrin a… Sepsis Toxemia Severe Sepsis | Data Safety Monitoring Board recommendation - | |||
| NCT00762359 Details | 2012-02-03 Interventional | 3 | 461 | Dexlansoprazole Gefarnate Lansoprazole Duodenal Ulcer Stomach Ulcer Ulcer | AG-1749 superior to Gefarnate in ulcer prevention On September 2008, the Efficacy and Safety Evaluation Committee recommended that this study be discontinued based on the interim analysis. | |||
| NCT00134264 Details | 2012-02-03 Interventional | 3 | 15067 | Atorvastatin Torcetrapib Coronary Diseas… Heart Diseases Diabetes Mellit… | - - | |||
| NCT00124748 NCT00324636 Details | 2012-02-03 Interventional | 3 | 476 | Imatinib Mesyla… Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… | This study was prematurely discontinued because no improvement was observed in the 800mg dose
compared to 400mg dose - | |||
| NCT00759720 Details | 2012-02-02 Interventional | 3 | 447 | Glyburide Diabetes Mellit… Diabetes Mellit… | Potential hepatic safety signal - | |||
| NCT01132404 2009-017668-18 Details | 2012-01-31 Interventional | 1/2 | 9 | Leuprolide Prostatic Neopl… Prostate Cancer | Developing new formulation of study drug. New study to open next year under a new protocol. - | |||
| NCT00969033 Details | 2012-01-31 Interventional | 2 | 8 | Irinotecan Colorectal Neop… Metastatic Colo… | - - | |||
| NCT00763685 2008-004098-17 Details | 2012-01-31 Interventional | 4 | 40 | Etoricoxib Pain, Postopera… Pain | The gynecological laparoscopic surgery transition to day surgery made following the study
protocol not possible. - | |||
| NCT01254136 Details | 2012-01-25 Interventional | 1/2 | - | Trastuzumab Vinorelbine Breast Neoplasm… Breast Cancer | Incyte has suspended development of the compound. - | |||
| NCT00613808 Details | 2012-01-25 Interventional | 2 | 6 | Nitric Oxide Ulcer Varicose Ulcer Venous Ulcers | - - | |||
| NCT00446303 Details | 2012-01-19 Interventional | 2 | 39 | Azacitidine Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Leukemia, Myelo… | - - | |||
| NCT00862472 Details | 2012-01-18 Interventional | 3 | 0 | Cloprostenol Timolol Glaucoma Glaucoma, Open-… Hypertension Ocular Hyperten… Open-angle Glau… | Management decision not to conduct an additional efficacy study. - | |||
| NCT01510288 Details | 2012-01-16 Interventional | 1 | 28 | Ipilimumab Prostatic Neopl… Prostate Cancer | The study was terminated because Cell Genesys stopped all activities for GVAX. - | |||
| NCT01015729 Details | 2012-01-16 Interventional | 1 | 30 | Esomeprazole Peptic Ulcer Peptic Ulcer Di… | - - |